{"id":721,"date":"2026-07-17T09:58:15","date_gmt":"2026-07-17T09:58:15","guid":{"rendered":"https:\/\/onestepblowmachine.com\/?p=721"},"modified":"2026-07-17T09:58:48","modified_gmt":"2026-07-17T09:58:48","slug":"injection-stretch-blow-moulding-machine-applications-in-pharmaceutical-bottle-manufacturing","status":"publish","type":"post","link":"https:\/\/onestepblowmachine.com\/sv\/ansokan\/injection-stretch-blow-moulding-machine-applications-in-pharmaceutical-bottle-manufacturing\/","title":{"rendered":"Injection Stretch Blow Moulding Machine Applications in Pharmaceutical Bottle Manufacturing"},"content":{"rendered":"
\n
\n

A technical guide for pharmaceutical packaging engineers, procurement specialists, and GMP compliance teams worldwide \u2014 covering how one-step injection stretch blow moulding machines produce pharma-grade PET and PP bottles, what machine structure and material systems are required, and how production meets international regulatory standards from the EU to India to Brazil.<\/p>\n<\/div>\n

<\/p>\n

\n

Pharmaceutical bottle manufacturing occupies a different category of difficulty from most plastic packaging applications. The consequences of a packaging failure in this sector \u2014 contaminated product reaching patients, incorrect dosing from a deformed or inconsistent closure, microbiological ingress through a neck finish that didn’t meet its specification \u2014 are not commercial problems alone. They are patient safety issues that can trigger product recalls, regulatory enforcement actions, and in the worst cases, direct harm to end users. This reality shapes every aspect of how pharmaceutical packaging equipment is specified, operated, and validated.<\/p>\n

De injection blow molding machine<\/strong> \u2014 specifically the one-step injection stretch blow moulding configuration \u2014 has become a primary production technology for pharmaceutical plastic bottles across a wide range of dosage forms and delivery formats. Its ability to produce precise, reproducible neck finishes for child-resistant closures, tamper-evident seals, and dropper fitments, combined with the contamination-free closed-loop production cycle and the optical clarity that allows visual inspection of liquid fill contents, makes it technically well suited to pharmaceutical packaging requirements that other blow moulding processes address less completely.<\/p>\n

This article covers the key dimensions of pharmaceutical bottle production on an formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong>: which pharmaceutical packaging formats benefit most from the process, what machine structural features are most relevant to GMP-compliant production, which resins are appropriate for different pharmaceutical applications, how the process supports equipment qualification documentation (IQ\/OQ\/PQ), and what regulatory requirements apply across the major pharmaceutical markets globally where these machines are being purchased, imported, and commissioned.<\/p>\n<\/div>\n

<\/p>\n

\n

1. Pharmaceutical Packaging Formats Produced by Injection Stretch Blow Moulding<\/h2>\n

The range of pharmaceutical bottle formats produced on an formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> is broader than many engineers outside the sector appreciate. The process handles formats from 5 ml ophthalmic dropper bottles to 500 ml oral liquid medicine containers, across resins including PET, PETG, PP, and PC \u2014 each chosen for the specific chemical and barrier requirements of the pharmaceutical product inside. Understanding which formats are most naturally served by the one-step process helps pharmaceutical packaging engineers identify where the technology offers its most compelling advantages.<\/p>\n

\n
\n

Ophthalmic Drop Bottles<\/h3>\n

Eye drop bottles in the 5\u201320 ml range represent one of the most precision-demanding pharmaceutical packaging formats. The dropper tip orifice diameter must be consistent to deliver calibrated drop volumes \u2014 typically 25\u201350 \u00b5l per drop \u2014 and the neck finish must provide a secure fitment for the dropper insert or nozzle cap. The one-step injection blow molding machine<\/strong> process forms this neck finish by injection moulding and maintains it unchanged through the blow phase, providing neck dimension repeatability that is critical for dosing accuracy.<\/p>\n<\/div>\n

\n

Oral Liquid Medicine Bottles<\/h3>\n

Syrup, suspension, and oral solution bottles in the 50\u2013500 ml range are produced in high volumes on four-station injection stretch blow moulding machines. PET’s oxygen barrier performance protects oxidation-sensitive active ingredients, and the biaxial orientation achieved in the one-step process produces bottles with the impact resistance needed for transit and in-pharmacy handling. Child-resistant closure compatibility requires precise neck finish dimensions \u2014 typically tolerance of \u00b10.1 mm on thread profile \u2014 that the one-step injection process delivers consistently.<\/p>\n<\/div>\n

\n

Tablet & Capsule Containers<\/h3>\n

Wide-mouth pill jars in 60\u2013500 ml formats require wall rigidity sufficient to protect contents from compression damage during shipping, moisture barrier performance adequate for hygroscopic drug products, and push-and-turn child-resistant closure compatibility. PP-based containers produced on a suitably configured formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> handle these requirements well, and the one-step process produces the consistent wide-mouth neck geometry that child-resistant closure systems depend on for reliable opening force performance.<\/p>\n<\/div>\n

\n

Topical & Nasal Packaging<\/h3>\n

Nasal spray bottles, topical cream dispensers, and wound care bottles combine demanding neck finish precision for pump fitment with clarity requirements that allow visual inspection of the product volume remaining in the container. PETG is frequently specified in this format category for its superior gloss and clarity in small volumes, while the one-step process’s contamination-free production cycle supports the particulate cleanliness requirements associated with topical pharmaceutical products that will be applied to broken skin or mucous membranes.<\/p>\n<\/div>\n<\/div>\n

\"Pharmaceutical<\/div>\n<\/div>\n

<\/p>\n

\n

2. Why the One-Step Process Suits GMP Pharmaceutical Bottle Production<\/h2>\n

Several structural characteristics of the one-step formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> process align naturally with the demands of pharmaceutical manufacturing environments. These are not incidental advantages \u2014 they reflect fundamental features of how the process works that GMP production facilities can document and validate as part of their quality management systems.<\/p>\n

Closed-loop contamination control.<\/strong> In the one-step process, the plastic material enters the machine as granules, is melted and injection moulded in a sealed environment, moves through the conditioning and blow stations without external handling, and exits as a finished bottle through the automated takeout mechanism. At no point does the preform or the bottle body contact ambient air, operator hands, or any surface outside the controlled machine environment before the bottle exits through the takeout. This closed-loop sequence is directly relevant to pharmaceutical packaging particulate contamination requirements \u2014 particularly for bottles intended for injectable preparations, ophthalmic products, or other dosage forms where particulate limits are quantitatively specified. Two-step reheat systems, where preforms are stored, transported, and loaded manually before reheating, introduce contamination exposure windows that the one-step process eliminates.<\/p>\n

Neck finish formed by injection, not by blowing.<\/strong> The neck of a pharmaceutical bottle carries the most critical functional dimensions in the entire package: the thread outer diameter and profile for the closure system, the sealing land geometry for liner-based seals, and the neck bore diameter for dropper inserts or valves. In the one-step process, these dimensions are formed by the injection mould in the first station and are not affected by the stretch-blow phase \u2014 which acts only on the bottle body below the support flange. This means that the neck finish dimensions of a pharmaceutical bottle produced on a one-step machine are as consistent as the injection mould itself, subject only to normal polymer shrinkage variation. The repeatability is substantially better than in extrusion blow moulding, where the neck is formed from an extruded parison and is more sensitive to extrusion rate and die head temperature variation.<\/p>\n

Process traceability for equipment qualification.<\/strong> GMP-compliant pharmaceutical bottle production requires that the production equipment can be qualified through Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols. The servo-driven machine architectures in this product range \u2014 with PLC-controlled process parameters, logged cycle data, and defined process limits \u2014 provide the documented process control foundation that IQ\/OQ\/PQ protocols require. Every servo position, temperature setpoint, blow pressure, and cycle time is defined in the machine control system and can be documented with traceability back to the validated process parameters established during OQ.<\/p>\n

\"One-step<\/div>\n<\/div>\n

<\/p>\n

\n

3. Machine Manufacturing Structure \u2014 Components That Matter for Pharmaceutical Applications<\/h2>\n

Selecting an formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> for pharmaceutical bottle production requires evaluating structural features beyond those that matter in general packaging applications. The following covers the machine components most directly relevant to pharmaceutical quality and compliance requirements.<\/p>\n

Servo Control Architecture and Process Repeatability<\/h3>\n

For pharmaceutical bottle production requiring documented process control, a servo-driven machine architecture provides the process repeatability and data availability that GMP validation requires. On fully servo-driven machines such as the EP-HGY50-V3-EV, every major axis \u2014 injection unit travel, turntable rotation, stretch rod descent, blow mold opening and closing, takeout \u2014 is controlled by a servo motor with positional feedback, giving the PLC the information it needs to confirm that each cycle executed within the validated process window. The turntable drive uses a Japan Yaskawa servo motor with a Taiwan TSUNTIEN reducer, providing angular positioning accuracy that maintains mold alignment across the production run \u2014 critical when neck finish concentricity is a pharmaceutical specification parameter. Servo motor power across the machine range spans from 34.8 kW on the three-station model to over 100 kW on larger four-station configurations, matching the drive capacity to the machine size and production rate.<\/p>\n

Injection Unit \u2014 Barrel, Screw, and Melt Quality<\/h3>\n

The injection unit is where plastic quality begins in the one-step process. Barrels manufactured from 38CrMoAlA nitrided steel with a surface hardness of 900\u20131000 HV resist wear from glass-filled or mineral-filled pharmaceutical resin grades that would rapidly erode standard barrel metallurgy. Screws from the same alloy or 42CrMo with hard chrome plating on flight surfaces handle the abrasive and chemically active processing environments of pharmaceutical resin compounds. Nano far-infrared energy-saving heating rings heat the barrel with high efficiency and uniformity, reducing the melt temperature variation across barrel length that is one of the primary sources of shot-to-shot injection volume variability. For pharmaceutical applications where preform weight consistency directly affects bottle wall thickness \u2014 and therefore the mechanical performance of the container \u2014 melt quality consistency is a production quality parameter, not merely an energy efficiency feature. NSK Japan ballscrews on precision linear axes ensure that injection stroke positioning is repeatable within the validated tolerance band across millions of production cycles.<\/p>\n

Temperature Conditioning System<\/h3>\n

The temperature conditioning station of the four-station machine is critical for pharmaceutical bottle production because it manages the thermal state of the preform between the injection and blow phases. For pharmaceutical containers produced in PP \u2014 which requires a narrower temperature window for adequate biaxial orientation than PET \u2014 precise temperature conditioning is especially important. The integrated control box temperature system provides high accuracy, stability, and ease of operation, with setpoint control across multiple heating and cooling zones. Cooling water pressure requirements of 0.4\u20130.6 MPa and temperature of 20\u201325 \u00b0C are maintained through the mold cooling circuit, and a matched mold temperature controller is the appropriate specification for pharmaceutical production facilities where temperature control documentation is part of the validated process record.<\/p>\n

High-Pressure Pneumatic and Hydraulic Systems<\/h3>\n

Parker USA high-pressure valves manage blow air at 2.0\u20133.5 MPa \u2014 the range required to fully inflate PET and PP pharmaceutical bottles against the blow mold cavity surfaces. For pharmaceutical applications where contamination of the bottle interior by oil vapour from the compressed air supply would be a critical quality deviation, the specification of an oil-free air compressor is essential and should be treated as a machine system requirement rather than an optional facility consideration. Airtac pneumatic cylinders handle secondary actuation functions, and YUKEN Taiwan hydraulic control valves manage clamping and injection unit hydraulic functions on hybrid servo-hydraulic machine configurations. Oil tubes on hydraulic machines are made from imported Italian materials specified for cyclic pressure fatigue performance in continuous production environments.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n
Component<\/th>\nMaterial \/ Specification<\/th>\nPharmaceutical Relevance<\/th>\n<\/tr>\n<\/thead>\n
Barrel<\/td>\n38CrMoAlA nitrided steel, 900\u20131000 HV surface<\/td>\nWear resistance for filled pharma resins; consistent melt quality<\/td>\n<\/tr>\n
Screw<\/td>\n42CrMo, hard chrome flight surfaces<\/td>\nShot-to-shot preform weight consistency<\/td>\n<\/tr>\n
Heating elements<\/td>\nNano far-infrared energy-saving rings<\/td>\nUniform barrel temperature; reduces thermal degradation risk<\/td>\n<\/tr>\n
Lead screws (servo axes)<\/td>\nNSK Japan, ISO C3 grade, SUJ2 bearing steel<\/td>\nInjection stroke repeatability for process validation<\/td>\n<\/tr>\n
Turntable drive<\/td>\nYaskawa Japan servo + TSUNTIEN reducer<\/td>\nNeck finish concentricity across production run<\/td>\n<\/tr>\n
High-pressure valve<\/td>\nParker USA, 2.0\u20133.5 MPa<\/td>\nConsistent blow pressure for wall thickness uniformity<\/td>\n<\/tr>\n
Hydraulic tubing<\/td>\nImported Italian seamless steel tube<\/td>\nPressure-cycle fatigue resistance for 24\/7 pharma production<\/td>\n<\/tr>\n
Preform mold inserts<\/td>\nS136 stainless tool steel, Ra \u2264 0.05 \u00b5m<\/td>\nCorrosion resistance, surface quality for pharma clarity<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

4. Material System \u2014 Resin Selection for Pharmaceutical Bottle Applications<\/h2>\n

Pharmaceutical bottle resin selection is governed by a more structured set of requirements than cosmetic or food packaging \u2014 including regulatory positive substance lists, pharmacopoeial standards, drug-packaging compatibility testing protocols, and in many markets, specific national approval pathways for packaging materials used with medicinal products. The following covers the primary resins processed on formsprutnings- och str\u00e4ckbl\u00e5sningsmaskiner<\/strong> for pharmaceutical applications, with notes on regulatory acceptance and key application suitability criteria.<\/p>\n

\n\n\n\n\n\n\n\n\n\n
Resin<\/th>\nKey Properties<\/th>\nPrimary Pharma Applications<\/th>\nPharmacopoeial Reference<\/th>\nKey Limitation<\/th>\n<\/tr>\n<\/thead>\n
S\u00c4LLSKAPSDJUR<\/strong><\/td>\nHigh clarity, O\u2082 barrier, impact resistance<\/td>\nOral syrups, suspensions, liquid vitamins<\/td>\nUSP <661>, EP 3.1.5, JP General Notices<\/td>\nNot autoclave-sterilisable; low max-use temperature<\/td>\n<\/tr>\n
PETG<\/strong><\/td>\nOutstanding clarity, amorphous, wide processing window<\/td>\nTopical preparations, nasal sprays, small-volume injectables (non-sterile)<\/td>\nUSP <661> (as modified PET)<\/td>\nLower barrier than oriented PET; solvent sensitivity<\/td>\n<\/tr>\n
PP<\/strong><\/td>\nChemical resistance, steam-sterilisable, wide temp range<\/td>\nOphthalmic drops, unit-dose ampoules, tablet jars<\/td>\nUSP <661> Type III, EP 3.1.6, IP<\/td>\nSemi-transparent; requires specific ISBM machine configuration<\/td>\n<\/tr>\n
PC (BPA-free)<\/strong><\/td>\nHigh impact strength, optical clarity, autoclave-compatible<\/td>\nReusable containers, hospital dispensing, lab packaging<\/td>\nUSP <661>; BPA-free grade required for product contact<\/td>\nHigh processing temp; BPA documentation required for compliance<\/td>\n<\/tr>\n
PCTG<\/strong><\/td>\nPC-like clarity, improved chemical resistance vs PETG<\/td>\nSpecialty pharma containers, sterile-fill packaging<\/td>\nCompliance per resin grade supplier; USP <661> applicable<\/td>\nNiche application; limited resin supplier network<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

PP is the pharmaceutical industry’s most widely trusted resin for primary packaging in direct contact with solid and semi-solid dosage forms, and for ophthalmic applications where the low extractables profile of PP under relevant extraction conditions is a key regulatory advantage. Producing PP pharmaceutical bottles on an formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> requires machine configurations specifically adapted for PP’s higher melt viscosity and narrower biaxial orientation temperature window \u2014 not all machines in the general ISBM range are configured for PP, and this should be confirmed with the supplier before specifying PP applications on a new machine. PET is the most common resin for oral liquid pharmaceutical products, while PETG serves niche applications where the amorphous clarity advantage justifies its higher cost and slightly lower barrier performance.<\/p>\n

\"Injection<\/div>\n<\/div>\n

<\/p>\n

\n

5. Equipment Qualification \u2014 Supporting IQ, OQ, and PQ for GMP Pharmaceutical Production<\/h2>\n

Every piece of production equipment in a GMP pharmaceutical manufacturing facility must go through a formal qualification process before it is used to produce product for clinical or commercial release. For an formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> used to produce pharmaceutical primary packaging, this means Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) \u2014 three sequential phases of documented testing that together demonstrate that the machine is installed correctly, operates within defined parameters, and consistently produces packaging that meets its specification.<\/p>\n

Installation Qualification (IQ)<\/strong> documents that the machine has been delivered and installed according to the manufacturer’s specifications and the site’s engineering design intent. The IQ protocol for a blow moulding machine typically covers: verification of machine model and serial number against the purchase order; confirmation of utility connections (voltage at 370\u2013400 V, compressed air supply capacity and oil-free status, cooling water pressure at 0.4\u20130.6 MPa and temperature); verification of safety systems including emergency stop circuits, guard interlock switches, and overload protection; and as-found documentation of all calibration certificates for temperature sensors, pressure gauges, and servo encoders. The machine supplier should provide a User Requirements Specification (URS) and a Functional Specification (FS) that serve as the baseline documents for the IQ protocol.<\/p>\n

Operational Qualification (OQ)<\/strong> demonstrates that the machine operates as designed across the full range of process parameters. For a pharmaceutical blow moulding application, OQ testing typically includes: verification that all temperature setpoints can be achieved and maintained within \u00b12 \u00b0C; confirmation of blow pressure control within \u00b10.1 MPa of setpoint; verification of servo axis positioning repeatability within the machine specification; demonstration of alarm response for out-of-tolerance conditions; and validation of cycle time consistency across a defined number of consecutive cycles. The OQ establishes the validated process parameter ranges \u2014 the window within which the machine must operate to produce conforming product \u2014 that are then documented in the site’s Master Batch Record or process validation report.<\/p>\n

Performance Qualification (PQ)<\/strong> confirms that the machine consistently produces pharmaceutical bottles that meet all specification requirements when operated within the OQ-validated process parameters. The PQ protocol for a pharmaceutical blow moulding application includes: preform weight consistency (typically \u00b10.5 g from target); bottle wall thickness distribution (measured at defined points around the bottle body); neck finish dimension verification (OD, neck height, thread profile); closure torque testing with the specified child-resistant or tamper-evident closure; particulate cleanliness testing per USP <788> or equivalent; and container closure integrity testing appropriate to the dosage form. A minimum of three consecutive PQ batches are normally required to demonstrate process consistency before the equipment is approved for commercial production use.<\/p>\n<\/div>\n

<\/p>\n

\n

6. Featured Machine \u2014 EP-HGYS150-V4: Four-Station ISBM for Pharmaceutical Bottle Production<\/h2>\n
\n

\n\"EP-HGYS150-V4
\n<\/a><\/div>\n
\n

The EP-HGYS150-V4 four-station enstegs formsprutningsstr\u00e4ckformningsmaskin<\/strong> is suited to pharmaceutical bottle production across a range of oral liquid, tablet, and topical packaging formats. Its four-station configuration \u2014 injection, temperature conditioning, stretch-blow, and takeout \u2014 provides the temperature conditioning precision that pharmaceutical PET and PP production requires, and its ASB-12M mold compatibility means that pharmaceutical producers currently running older ASB-format equipment can transition to this machine while retaining existing validated mold tooling assets.<\/p>\n

The machine runs 3 servo pump systems (Inovance \/ WEICHI) at 43.2 kW combined motor power, with integrated temperature control box management across all station zones. Screw diameter options of 40, 50, 55, and 60 mm cover the injection volume range from 188 cm\u00b3 to 480 cm\u00b3 per shot \u2014 serving pharmaceutical bottle formats from 30 ml ophthalmic packs to 500 ml oral liquid bottles within the same machine platform. Parker USA high-pressure valves at 2.0\u20133.5 MPa manage the blow air circuit, and the hydraulic system uses YUKEN Taiwan control valves with Italian-imported tubing for reliability in continuous multi-shift pharmaceutical production environments.<\/p>\n

The machine processes PET and PETG resins at standard configuration. For pharmaceutical PP applications, confirm PP capability with the technical sales team at the quotation stage as specific screw geometry and temperature parameter adjustments may be required. The ASB-12M mold compatibility is a practically significant feature for pharmaceutical producers evaluating this as a ers\u00e4ttningssprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> for existing ASB-equipped lines, as it allows validated mold tooling to transfer to the new machine and reduces the PQ scope from a full tooling validation to a machine-level process re-qualification.<\/p>\n<\/div>\n<\/div>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Parameter<\/th>\nEnhet<\/th>\nV\u00e4rde<\/th>\n<\/tr>\n<\/thead>\n
Modell<\/td>\n\u2014<\/td>\nEP-HGYS150-V4 (4-station, ASB-12M compatible)<\/td>\n<\/tr>\n
Compatible Material<\/td>\n\u2014<\/td>\nPET \/ PETG<\/td>\n<\/tr>\n
Skruvdiameter (valfritt)<\/td>\nMM<\/td>\n40 \/ 50 \/ 55 \/ 60<\/td>\n<\/tr>\n
Teoretisk injektionsvolym<\/td>\nCM\u00b3<\/td>\n188 \/ 310 \/ 380 \/ 480<\/td>\n<\/tr>\n
Injektionskl\u00e4mkraft<\/td>\nKN<\/td>\n150<\/td>\n<\/tr>\n
Bl\u00e5sande kl\u00e4mkraft<\/td>\nKN<\/td>\n200 (enkel sida)<\/td>\n<\/tr>\n
Motorkraft<\/td>\nKW<\/td>\n43.2<\/td>\n<\/tr>\n
V\u00e4rmekraft<\/td>\nKW<\/td>\n10<\/td>\n<\/tr>\n
Bl\u00e5slufttryck<\/td>\nMPa<\/td>\n2,0\u20133,5<\/td>\n<\/tr>\n
Kylvattentryck<\/td>\nMPa<\/td>\n0,4\u20130,6<\/td>\n<\/tr>\n
Sp\u00e4nning<\/td>\nV<\/td>\n370\u2013400<\/td>\n<\/tr>\n
Machine Size (L\u00d7W\u00d7H)<\/td>\nMM<\/td>\n4200 \u00d7 1400 \u00d7 2900<\/td>\n<\/tr>\n
Maskinvikt<\/td>\nT<\/td>\n6<\/td>\n<\/tr>\n
Mold Compatibility<\/td>\n\u2014<\/td>\nJapanese ASB-12M format<\/td>\n<\/tr>\n
Max. Bottle Volume Range<\/td>\nML<\/td>\n20\u20132,500 (cavity-dependent)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

7. International Regulatory Requirements for Pharmaceutical Bottle Production and Machine Compliance<\/h2>\n

Pharmaceutical packaging is among the most heavily regulated material categories globally, and the regulatory requirements that apply to bottles produced on an formsprutningsstr\u00e4ckformbl\u00e5sningsmaskin<\/strong> differ significantly between markets in their specifics while sharing common underlying principles: the packaging must not harm the patient, must not contaminate the drug product, and must be consistently manufactured to a documented specification. The following covers the major regulatory frameworks governing pharmaceutical plastic packaging and machinery compliance in key global markets.<\/p>\n

European Union \u2014 EU Pharmaceutical Packaging Regulation<\/h3>\n

In the EU, pharmaceutical packaging materials are regulated as components of the medicinal product under Directive 2001\/83\/EC (the Community code for human medicines) and Regulation (EC) 726\/2004 for centrally authorised products. The European Pharmacopoeia (Ph. Eur.) Chapter 3.1 specifies requirements for plastic materials used in pharmaceutical containers, including 3.1.5 (polyethylene with additives), 3.1.6 (polypropylene), and relevant sections for other polymers. The blow moulding machine itself must carry CE marking in conformity with the EU Machinery Directive 2006\/42\/EC. GMP requirements under EU GMP Annex 11 (computerised systems) apply to PLC-controlled production equipment in GMP environments, requiring that the machine’s control system is validated and that electronic batch records maintain audit trail compliance. German market requirements additionally involve documentation under the German Medicinal Products Act (AMG, Arzneimittelgesetz) for packaging materials used with medicinal products licensed in Germany.<\/p>\n

United States \u2014 FDA 21 CFR and cGMP<\/h3>\n

In the United States, pharmaceutical packaging materials for human drugs are regulated under the FDA’s cGMP regulations (21 CFR Parts 210 and 211 for finished drug products, and 21 CFR Part 4 for combination products). USP General Chapter <661> (Plastic Packaging Systems and their Materials of Construction) provides the primary material standard for plastic pharmaceutical containers, covering test requirements for extractables, physicochemical tests, and biological reactivity. USP <671> covers container performance requirements including light transmission. The FDA’s Container Closure Guidance (August 1999, Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics) outlines the submission requirements for packaging information in New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs). Machine import compliance requires OSHA 29 CFR 1910 general industry machinery standards and NFPA 79 electrical standards, with many pharmaceutical facilities additionally requiring NRTL certification for electrical panels before the machine can operate in the facility.<\/p>\n

India \u2014 CDSCO, IP Standards, and Drugs and Cosmetics Act<\/h3>\n

India’s pharmaceutical packaging regulatory framework is administered by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940 (as amended). The Indian Pharmacopoeia (IP) General Chapter on Containers specifies requirements for plastic containers used with pharmaceutical preparations, with classifications (Type I\u2013IV) aligned broadly with the USP\/EP framework. Schedule M of the Drugs and Cosmetics Act establishes GMP requirements for pharmaceutical manufacturers, including specifications for packaging material testing and approved supplier qualification. India’s large and growing pharmaceutical manufacturing sector \u2014 making it one of the world’s largest producers of generic medicines \u2014 creates significant demand for injection blow molding machine<\/strong> pharmaceutical packaging capacity, and machine imports must comply with the Bureau of Indian Standards (BIS) requirements and applicable customs classifications under India’s Foreign Trade Policy.<\/p>\n

Brazil \u2014 ANVISA Pharmaceutical Packaging Standards<\/h3>\n

ANVISA (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria) regulates pharmaceutical packaging in Brazil under Resolution RDC 185\/2001 and subsequent resolutions covering plastic packaging materials for medicinal products. Brazilian GMP requirements under RDC 204\/2017 align closely with WHO GMP guidelines and the EU GMP framework, requiring documented equipment qualification (validation) for production equipment including blow moulding machines. Packaging material suppliers must register with ANVISA and provide technical documentation demonstrating compliance with Farmacopeia Brasileira (FB) standards for plastic containers. Brazil’s NR-12 machinery safety standard applies to the blow moulding machine itself and requires documented risk assessment, safeguarding, and emergency stop compliance.<\/p>\n

Japan \u2014 PMDA and JP Standards<\/h3>\n

Japan’s pharmaceutical packaging regulatory framework is administered by the Pharmaceuticals and Medical Devices Agency (PMDA) under the Act on Securing Quality, Efficacy, and Safety of Pharmaceuticals, Medical Devices, Quasi-Pharmaceutical Products, Cosmetics, Medical Devices, and Regenerative Medical Products (Pharmaceutical Affairs Act, 2014 revision). The Japanese Pharmacopoeia (JP) General Tests for plastic containers provide material standards, and plastic containers used in pharmaceutical applications must meet JP specifications for the applicable container type. Japan is a particularly important market for pharmaceutical ISBM machine production because the major Japanese pharmaceutical companies \u2014 operating under PMDA oversight \u2014 represent sophisticated buyers with detailed technical requirements for packaging equipment suppliers, and machines must typically be capable of producing pharmaceutical bottles compatible with Japanese child-resistant closure standards.<\/p>\n

\n\n\n\n\n\n\n\n\n\n
Market<\/th>\nRegulatory Body<\/th>\nPackaging Material Standard<\/th>\nMachine Compliance Requirement<\/th>\nGMP Framework<\/th>\n<\/tr>\n<\/thead>\n
EU<\/td>\nEMA \/ National authorities<\/td>\nPh. Eur. 3.1.x series<\/td>\nCE Machinery Directive 2006\/42\/EC<\/td>\nEU GMP Annex 11 (computerised systems)<\/td>\n<\/tr>\n
USA<\/td>\nFDA<\/td>\nUSP <661>, <671>; 21 CFR 211<\/td>\nOSHA 1910, NFPA 79, NRTL cert<\/td>\n21 CFR Parts 210\/211 cGMP<\/td>\n<\/tr>\n
India<\/td>\nCDSCO<\/td>\nIndian Pharmacopoeia (IP) containers chapter<\/td>\nBIS, import customs classification<\/td>\nSchedule M, Drugs and Cosmetics Act<\/td>\n<\/tr>\n
Brasilien<\/td>\nANVISA<\/td>\nFarmacopeia Brasileira (FB), RDC 185\/2001<\/td>\nNR-12 machinery safety<\/td>\nRDC 204\/2017 (WHO-aligned GMP)<\/td>\n<\/tr>\n
Japan<\/td>\nPMDA<\/td>\nJapanese Pharmacopoeia (JP) General Tests<\/td>\nElectrical safety JIS standards<\/td>\nPharmaceutical Affairs Act (2014)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Explore Injection Stretch Blow Moulding Machines for Pharmaceutical Packaging<\/h2>\n

From compact three-station machines for ophthalmic and small-volume pharmaceutical formats to high-output four-station configurations for oral liquid and tablet packaging lines \u2014 find the machine specification that matches your pharmaceutical production requirements.<\/p>\n

\u00a0ISBM-maskiner<\/a>
\nEuropean Type IBM Machines<\/a>
\nContact a Specialist<\/a><\/div>\n<\/div>\n

<\/p>\n

\n

Om oss<\/h2>\n

With over two decades of experience developing and manufacturing one-step injection stretch blow moulding machines for pharmaceutical, cosmetic, food, and beverage packaging, our production facility covers more than 20,000 square meters and operates a complete supply chain from machine design and precision machining through assembly, testing, and commissioning support. The engineering team has filed multiple national patents in machine design and process control, and has developed machine configurations used in pharmaceutical packaging facilities across Asia, Europe, India, Brazil, the Middle East, and other regulated markets.<\/p>\n

Component sourcing reflects pharmaceutical production standards: servo drive systems from Inovance and Yaskawa Japan, NSK Japan ballscrews on precision axes, Parker USA high-pressure blow air valves, and YUKEN Taiwan hydraulic control systems. For pharmaceutical applications requiring equipment qualification documentation, the technical team can support the preparation of User Requirements Specifications, Functional Specifications, and instrument calibration records that form the baseline documentation for IQ\/OQ protocols. Machines compatible with Japanese ASB mold formats (ASB-12M and ASB-70DPH) allow pharmaceutical producers to transfer validated mold tooling to new machine generations, reducing the scope and cost of re-qualification programs at existing sites.<\/p>\n

Verkstad<\/h3>\n
\n
\"Verkstadsvy
\n\"Verkstadsvy
\n\"Verkstadsvy
\n\"Production<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Related System Solutions<\/h2>\n

Pharmaceutical bottle production demands auxiliary equipment that meets the same reliability and cleanliness standards as the main blow moulding machine. Two system components are critical \u2014 and their specification should be planned as part of the complete installation design rather than resolved post-commissioning.<\/p>\n

\n
\n

Oil-Free Air Compressor<\/a><\/h3>\n

In pharmaceutical bottle production, blow air at 2.0\u20133.5 MPa contacts the interior surface of the bottle during the blow phase and must be free of oil vapour, moisture, and particulates. An oil-contaminated blow air supply introduces hydrocarbon contamination into the bottle interior that cannot be removed by post-production rinsing in most pharmaceutical packaging workflows. For GMP compliance, the oil-free status of the blow air supply should be documented as part of the IQ protocol, with oil vapour concentration testing at the machine inlet per ISO 8573 air quality standards. An oil-free compressor<\/a> sized to the machine’s blow air demand is the correct and only appropriate specification for pharmaceutical blow moulding applications.<\/p>\n

\"Oil-free<\/p>\n<\/div>\n

\n

Formtemperaturregulator<\/h3>\n

Stable mold cooling water temperature at 20\u201325 \u00b0C is a validated process parameter in GMP pharmaceutical bottle production \u2014 it is part of the OQ and PQ record, not an informal operating condition. A mold temperature controller with calibrated temperature output and data logging capability allows the cooling water temperature to be included in the documented process parameters and monitored against the validated limits. For pharmaceutical facilities using electronic batch record systems, a mold temperature controller with data output connectivity supports integration into the site’s process monitoring infrastructure. Specifying a matched controller alongside the machine simplifies the OQ protocol validation scope and eliminates the cooling water temperature as a source of unexplained process variation during PQ.<\/p>\n

\"Mold<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Vanliga fr\u00e5gor<\/h2>\n
\nQ1. How does the one-step injection stretch blow moulding machine process help pharmaceutical manufacturers maintain GMP compliance in oral liquid bottle production?<\/summary>\n
The one-step process contributes to GMP compliance in several documented ways: the closed-loop production cycle eliminates the preform handling and storage steps where contamination exposure occurs in two-step systems; the servo-driven machine architecture provides PLC-controlled, logged process parameters that can be validated through IQ\/OQ\/PQ protocols; the injection-formed neck finish produces repeatable neck dimensions for child-resistant closure fitment; and the fully automated takeout eliminates operator contact with the bottle interior during production. Together, these characteristics are documented in the machine’s Functional Specification and User Requirements Specification, forming the baseline for the GMP equipment qualification documentation required for pharmaceutical packaging production lines in all major regulated markets.<\/div>\n<\/details>\n
\nQ2. Which injection stretch blow moulding machine model is best suited for pharmaceutical ophthalmic drop bottle production in a GMP facility in India?<\/summary>\n
For ophthalmic drop bottle production in a GMP facility in India, the EP-HGY50-V3-EV three-station fully servo machine offers a practical starting configuration. Its compact footprint (3800 \u00d7 1200 \u00d7 2500 mm), servo precision, and PET\/PETG resin compatibility handle the 5\u201330 ml ophthalmic bottle format range effectively. For PP ophthalmic bottles \u2014 where PP’s lower extractables profile under aqueous extraction conditions is a key advantage for eye preparations \u2014 confirm PP capability with the technical team at quotation stage. Indian CDSCO and Schedule M requirements apply, and BIS documentation for the machine import should be requested from the supplier as part of the procurement process.<\/div>\n<\/details>\n
\nQ3. What USP standards govern the plastic resin used in pharmaceutical bottles produced on an injection blow molding machine in the United States?<\/summary>\n
For pharmaceutical bottles produced on an injection blow molding machine and sold in the US market, the primary USP standard is General Chapter <661> (Plastic Packaging Systems and their Materials of Construction), which covers identification of the polymer type, physicochemical tests (appearance, heavy metals, non-volatile residue, residue on ignition), and biological reactivity testing (USP <87> and <88>). USP General Chapter <671> covers container performance \u2014 light transmission and moisture permeation \u2014 for containers in official compendial monographs. PET containers are additionally evaluated under the FDA’s container closure guidance, and resin suppliers typically provide certificates of compliance referencing USP <661> test results for their pharmaceutical-grade resin products. Confirm with the resin supplier that the specific resin grade and lot used in production carries appropriate USP compliance documentation before submitting packaging information in an NDA or ANDA.<\/div>\n<\/details>\n
\nQ4. How should pharmaceutical manufacturers in Brazil obtain ANVISA-compliant documentation for plastic bottles produced by an injection blow moulding machine supplier?<\/summary>\n
For ANVISA compliance, Brazilian pharmaceutical manufacturers need documentation from two separate sources: from the resin supplier, a declaration of compliance with Farmacopeia Brasileira (FB) standards for plastic containers and, where required, migration test data from INMETRO-accredited laboratories; and from the machine supplier, documentation supporting GMP equipment qualification including the Functional Specification, instrument calibration certificates, and \u2014 for NR-12 compliance \u2014 the risk assessment and safety circuit documentation required under Brazil’s machinery safety standard. The machine supplier should be asked at the quotation stage to confirm what qualification documentation they can provide and whether their after-sales technical team has experience supporting pharmaceutical facility validations in the Brazilian market. Use the contact section on this page for a proposal that addresses Brazilian ANVISA and NR-12 documentation requirements.<\/div>\n<\/details>\n
\nQ5. What makes an injection stretch blow moulding machine suitable as a replacement for older ASB pharmaceutical packaging equipment while preserving existing validated mold tooling?<\/summary>\n
The key to preserving validated mold tooling when replacing older ASB equipment is selecting a replacement injection stretch blow moulding machine with documented ASB mold format compatibility \u2014 specifically the tie-rod pitch, platen hole pattern, mold height range, and clamping stroke that matches the ASB format in use. The EP-HGYS150-V4 is documented as compatible with Japanese ASB-12M mold tooling, and the EP-HGY250-V4 with ASB-70DPH tooling. Where mold tooling transfers successfully to a replacement machine, the re-qualification scope is reduced: rather than a full IQ\/OQ\/PQ covering both machine and tooling from scratch, the tooling qualification may be limited to a shortened Performance Qualification confirming that the new machine produces bottles meeting the existing mold specification. This can reduce the total qualification timeline by several months \u2014 a significant commercial advantage in pharmaceutical packaging plant upgrades. Dimensional verification of mold plate compatibility before order placement is essential to confirm the transfer is feasible.<\/div>\n<\/details>\n
\nQ6. Which resin should pharmaceutical packaging engineers in Southeast Asia specify for child-resistant tablet containers produced on an injection stretch blow moulding machine?<\/summary>\n
PP is the preferred resin for child-resistant tablet containers for several well-established reasons: its chemical resistance to the moisture-absorbing salts and organic compounds in many solid dosage forms; its compatibility with desiccant-inserted packaging systems; its sterilisability where required for certain sterile solid forms; and its compliance with USP <661> Type III container requirements that are referenced across ASEAN pharmaceutical regulatory frameworks. PP’s semi-transparent character is acceptable for tablet containers where the closure system \u2014 not the container transparency \u2014 is the primary functional requirement. Confirm machine PP capability at the quotation stage, as not all injection stretch blow moulding machine configurations in the standard range are set up for PP production; screw geometry and temperature range adjustments may be required and should be specified before machine order placement.<\/div>\n<\/details>\n
\nQ7. How does particulate contamination testing under USP and Ph. Eur. standards affect the specification of an injection blow molding machine for sterile pharmaceutical packaging applications?<\/summary>\n
USP General Chapter <788> and Ph. Eur. Section 2.9.19 specify particulate contamination limits for injectable preparations \u2014 for example, not more than 6,000 particles \u226510 \u00b5m and not more than 600 particles \u226525 \u00b5m per container for large-volume injections. While the blow moulded container is not directly filled on the blow moulding machine, the particulate cleanliness of the container interior at the point of filling depends on the container having been produced in a controlled environment and handled cleanly between production and filling. For pharmaceutical packaging applications where the containers will be filled with sterile products, the machine installation environment (room classification), the cleanliness of the blow air supply (oil-free, filtered per ISO 8573 quality classes), and the container storage and transfer protocols between blow moulding and filling are all relevant to achieving the required particulate levels at the point of fill. These requirements should be reviewed with a qualified person (QP) or regulatory affairs specialist before machine specification is finalised.<\/div>\n<\/details>\n
\nQ8. Where can pharmaceutical packaging manufacturers in the UK find injection blow molding machine suppliers who can support MHRA GMP compliance documentation post-Brexit?<\/summary>\n
UK pharmaceutical packaging manufacturers operating under MHRA GMP oversight should look for machine suppliers with documented experience supporting equipment qualification in UK-regulated pharmaceutical environments, specifically those who can provide or coordinate a User Requirements Specification, Functional Specification, and instrument calibration documentation in a format compatible with MHRA inspection expectations. Post-Brexit, the UK’s Medicines and Healthcare Products Regulatory Agency applies the UK Good Manufacturing Practice regulations (aligned with EU GMP but administered independently), and packaging material compliance requirements reference the British Pharmacopoeia (BP) alongside EU\/US pharmacopoeial standards. UKCA marking requirements for machinery under the UK Machinery Directive equivalent should also be confirmed for machines installed in UK facilities. Use the contact section on this page to discuss UK-specific documentation requirements with a technical specialist.<\/div>\n<\/details>\n<\/div>\n<\/div>\n

Redakt\u00f6r: PXY<\/p>","protected":false},"excerpt":{"rendered":"

A technical guide for pharmaceutical packaging engineers, procurement specialists, and GMP compliance teams worldwide \u2014 covering how one-step injection stretch blow moulding machines produce pharma-grade PET and PP bottles, what machine structure and material systems are required, and how production meets international regulatory standards from the EU to India to Brazil. Pharmaceutical bottle manufacturing occupies […]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[28],"tags":[],"class_list":["post-721","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-medical-packaging"],"_links":{"self":[{"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/posts\/721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/comments?post=721"}],"version-history":[{"count":3,"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/posts\/721\/revisions"}],"predecessor-version":[{"id":724,"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/posts\/721\/revisions\/724"}],"wp:attachment":[{"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/media?parent=721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/categories?post=721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/onestepblowmachine.com\/sv\/wp-json\/wp\/v2\/tags?post=721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}